Exhibit 1
EXHIBIT 1
JOINT FILING AGREEMENT
February 12, 2021
Pursuant to Rule 13d-1(k)(1)(iii) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agrees that ISRAEL HEALTHCARE VENTURES 2 L.P. (“IHCV 2”) may file as necessary on behalf of the undersigned with the Securities and Exchange Commission a Schedule 13G or Schedule 13D and any amendments thereto in respect of shares of Gamida Cell Ltd. purchased, owned or sold from time to time by the undersigned.
IHCV 2 is hereby authorized to file a copy of this letter as an exhibit to said Schedule 13G or Schedule 13D or any amendments thereto.
ISRAEL HEALTHCARE VENTURES 2 L.P. | ||
By: | IHCV2 GENERAL PARTNER LIMITED | |
By: | /s/ Paddy M Whitford | |
Name: | Paddy M. Whitford | |
Title: | Director |
IHCV2 GENERAL PARTNER LIMITED | ||
By: | /s/ Paddy M Whitford | |
Name: | Paddy M. Whitford | |
Title: | Director | |
Gordon R.L. Snelling |
By: | /s/ Gordon R.L. Snelling | |
Paddy M. Whitford | ||
By: | /s/ Paddy M Whitford |